By Ujjwal Gupta and Charlotte Vangsgaard

Why pharma needs to focus on improving—not just extending life.

There are no market incentives for building a practical roadmap to this change. Philanthropists have to fund and deploy it, and those who do will emerge as the philanthropic role models of tomorrow. Those who don’t, risk their goodwill, a public backlash, and at worst, perpetuating, not solving, inequities.

Read the full article on Alliance Magazine.